Jan Mäkelä says WSA will win market share excluding the lost managed care contract, even though its guidance is far below Demant’s and Sonova’s.
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate strategy update with no direct implications for clinical practice.
WSA's US market challenges and below-peer guidance signal potential competitive shifts in hearing aid distribution that could affect clinic partnerships and product availability.
- 01WSA CEO Jan Mäkelä expects market share gains despite losing a US managed care contract.
- 02WSA's financial guidance is set well below competitors Demant and Sonova.
- 03Loss of a managed care contract represents a meaningful US headwind for WSA.
- 04CEO confidence is based on internal strategy, not disclosed clinical or product data.
- 05Competitive dynamics among the top hearing aid groups may affect dispenser supply chains.
WSA expects to gain market share despite losing a managed care contract and issuing guidance below competitors.
quoteunclear